View all newsletters
Receive our newsletter - data, insights and analysis delivered to you
  1. Theme
  2. Macro
  3. Covid-19
May 22, 2020

How the University of Oxford is leading the Covid-19 fight on multiple fronts

By Jamie Bell

While numerous large pharmaceutical companies and biotech firms have come forward and assisted global endeavours to uncover a Covid-19 vaccine, research teams at the University of Oxford have also placed themselves firmly at the forefront of these ongoing efforts.

Not only is it developing and testing its own vaccine candidate — which pharma giant AstraZeneca has already agreed to manufacture, and distribute, once it passes clinical testing — but it’s now heavily involved in the hunt for an effective coronavirus treatment too.

We take a closer look at how the world’s second-oldest university is contributing to the global fight against Covid-19 on multiple fronts.

Read the full article here.

Related Companies

NEWSLETTER Sign up Tick the boxes of the newsletters you would like to receive. Key drug pipeline and competitive landscape changes based on the latest clinical activity, sent every Tuesday. Curated analysis and data-driven insights on clinical trials strategy and operations, sent every Thursday. The pharmaceutical industry's most comprehensive news and information delivered every month.
I consent to GlobalData UK Limited collecting my details provided via this form in accordance with the Privacy Policy
SUBSCRIBED

THANK YOU

Thank you for subscribing to Clinical Trials Arena